Overview
"Oliver Schein, M.D., M.P.H., is the Burton E. Grossman Professor of Ophthalmology at the Wilmer Eye Institute and carries a joint appointment in the Department of Epidemiology at the Johns Hopkins University Bloomberg School of Public Health. Dr. Schein's clinical expertise is in medical and surgical conditions of the anterior segment of the eye including cataract and complications of cataract surgery, corneal scarring and corneal surgery. He is a past author of the American Academy of Ophthalmology's ""Preferred Practice Pattern"" on Cataract. Research activities are directed toward the epidemiology of major ocular diseases, ophthalmic technology assessment and outcomes research in ophthalmology. Dr. Schein received his M.D. and M.P.H. degrees from Johns Hopkins University and completed his ophthalmology residency and cornea and external eye disease fellowship at Harvard University's Massachusetts Eye and Ear Infirmary. He joined the Wilmer faculty in 1988.".
Dr. Schein is highly rated in 7 conditions, according to our data. His top areas of expertise are Cataract, Endophthalmitis, Fuchs Dystrophy, Cataract Removal, and Vitrectomy.
His clinical research consists of co-authoring 57 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Pavilion II STE 455, Lutherville, MD 21093
1800 Orleans Street, Maumenee Lobby, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Office
Janet Sunness is an Ophthalmologist in Towson, Maryland. Dr. Sunness is highly rated in 16 conditions, according to our data. Her top areas of expertise are Stargardt Macular Degeneration, Geographic Atrophy, Late-Onset Retinal Degeneration, and Age-Related Macular Degeneration (ARMD).
The Johns Hopkins Hospital
Peter A. Campochiaro, M.D. is the George S. and Dolores Doré Eccles Professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. He is a clinician-scientist who directs a research laboratory and conducts clinical trials. His laboratory research is directed at understanding the pathogenesis of ocular neovascularization and excessive retinal vascular permeability, and the mechanism of cone cell death in inherited retinal degenerations. He helped to determine the importance of vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1, and Tie2 in retinal and choroidal vascular diseases. The clinical trial group under Dr. Campochairo provided the first demonstration of the benefits of suppression of VEGF in diabetic macular edema and retinal vein occlusion. He has developed strategies for sustained suppression of VEGF that are currently being tested in clinical trials. Dr. Campochiaro trained at the University of Notre Dame, Johns Hopkins School of Medicine, and the University of Virginia. He did a vitreoretinal fellowship and research fellowships at Johns Hopkins and joined the faculty of the University of Virginia in 1984. He became professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins in 1991. Dr. Campochiaro is highly rated in 18 conditions, according to our data. His top areas of expertise are Retinal Vein Occlusion, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Trabeculectomy, and Vitrectomy.
Brian Brooks is an Ophthalmologist in Washington, Washington, D.c.. Dr. Brooks is highly rated in 29 conditions, according to our data. His top areas of expertise are Coloboma, Albinism, Oculocutaneous Albinism Type 2, and Oculocutaneous Albinism Type 1.
Frequently Asked Questions about Dr. Oliver D. Schein
How do I make an appointment with Dr. Oliver D. Schein?
You can book an appointment with Dr. Oliver D. Schein by calling their office at 410-583-2800. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Oliver D. Schein a top-rated expert for Cataract?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Oliver D. Schein is classified as an Distinguished expert for Cataract, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Oliver D. Schein specialize in?
While Dr. Oliver D. Schein is a Ophthalmology, they have specific expertise in Cataract, Endophthalmitis, and Cataract Removal. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Ophthalmology.
Does Dr. Oliver D. Schein participate in research or clinical trials?
Yes. Dr. Oliver D. Schein has published 57 articles and abstracts on conditions like Cataract. You can view a list of Dr. Oliver D. Schein's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Oliver D. Schein accept my insurance?
Dr. Oliver D. Schein accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 410-583-2800 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- CataractDr. Schein isDistinguished. Learn about Cataract.
- Cataract RemovalDr. Schein isDistinguished. Learn about Cataract Removal.
- EndophthalmitisDr. Schein isDistinguished. Learn about Endophthalmitis.
- Advanced
- Corneal Dystrophy and Perceptive Deafness
- Fuchs DystrophyDr. Schein isAdvanced. Learn about Fuchs Dystrophy.
- Macular Corneal Dystrophy Type 1Dr. Schein isAdvanced. Learn about Macular Corneal Dystrophy Type 1.
- VitrectomyDr. Schein isAdvanced. Learn about Vitrectomy.
- Experienced
- Age-Related Macular Degeneration (ARMD)Dr. Schein isExperienced. Learn about Age-Related Macular Degeneration (ARMD).
- AmebiasisDr. Schein isExperienced. Learn about Amebiasis.
- BlepharitisDr. Schein isExperienced. Learn about Blepharitis.
- Chandler's SyndromeDr. Schein isExperienced. Learn about Chandler's Syndrome.
- Cogan-Reese SyndromeDr. Schein isExperienced. Learn about Cogan-Reese Syndrome.
- Corneal TransplantDr. Schein isExperienced. Learn about Corneal Transplant.